RISPERIDONE ER 50 MG VIAL

What it is

RISPERIDONE ER 50 MG VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as risperidone.

FDA gives its dosage form as kit and its route as intramuscular.

Its labelers, the companies named on the label, are Teva Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC and Lupin Pharmaceuticals, Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 7 NDCs (National Drug Codes); the FDA directory lists 3 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $760.22 for 1 unit (EA) (1 × $760.21785 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

The 3 labelers

When these prices took effect

• 2026-09-30 · 1 NDC · $760.21785 per EA filed
• 2026-09-23 · 6 NDCs · $760.21785 per EA filed

Other strengths, forms and brands

30 other products in the NADAC file share the FDA nonproprietary name risperidone with RISPERIDONE ER 50 MG VIAL. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

What Medicare paid

Medicare Part B’s payment limit for HCPCS J2794, for 2026-10-01 to 2026-12-31, comes to $1,066.20 for 1 unit (EA), or $1,066.20 per EA once converted to NADAC’s unit for this product.

Medicare Part B pays for a drug like this only in specific settings, such as a drug given in a clinic or doctor’s office or used with certain medical equipment; most prescriptions filled at a pharmacy are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $2.1324 per 0.5 MG.

3 of the product’s 7 NDCs have this Medicare figure; the other 4 do not, and the interactive card says why for each.

Medicare's price is not your price.

What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 unit (EA)? Is it lower than what I would pay through my insurance?
• If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.